Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263874
Status:
TERMINATED
Last Update Posted:
2007-07-23
First Post:
2005-12-08
Brief Title:
Phase 2 Study of the Safety and Efficacy of UK-500001 in Adult Patients With COPD
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase II Randomized Double-Blind Placebo-Controlled Parallel Group Study To Evaluate The Efficacy And Safety Of UK-500001 Dry Powder For Inhalation DPI In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease COPD
Status:
TERMINATED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The decision to terminate was completely related to efficacy and there were no safety concerns
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This initial proof of concept phase II study aims to assess the safety and efficacy of UK-500001 for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None